But a team of researchers believes 3D-printed “polypills” could help kickstart a wave of “next-generation personalized medicines” and simplify medical routines.

Leveraging Insilico Medicine's exceptional AI capabilities, researchers are equipped with a powerful ally in their quest for groundbreaking advancements in target identification and drug development.